| Product NDC: | 0006-0072 | 
| Proprietary Name: | PROSCAR | 
| Non Proprietary Name: | FINASTERIDE | 
| Active Ingredient(s): | 5 mg/1 & nbsp; FINASTERIDE | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, FILM COATED | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0006-0072 | 
| Labeler Name: | Merck Sharp & Dohme Corp. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA020180 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19920619 | 
| Package NDC: | 0006-0072-31 | 
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (0006-0072-31) | 
| NDC Code | 0006-0072-31 | 
| Proprietary Name | PROSCAR | 
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (0006-0072-31) | 
| Product NDC | 0006-0072 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | FINASTERIDE | 
| Dosage Form Name | TABLET, FILM COATED | 
| Route Name | ORAL | 
| Start Marketing Date | 19920619 | 
| Marketing Category Name | NDA | 
| Labeler Name | Merck Sharp & Dohme Corp. | 
| Substance Name | FINASTERIDE | 
| Strength Number | 5 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | 5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA] |